Balance Sheet
Cash Flow Statement
AmortizationAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Legend Biotech (LEGN) Other Working Capital Changes (2020 - 2025)

Historic Other Working Capital Changes for Legend Biotech (LEGN) over the last 6 years, with Q3 2025 value amounting to -$1.2 million.

  • Legend Biotech's Other Working Capital Changes rose 9103.62% to -$1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$99.2 million, marking a year-over-year decrease of 12587.36%. This contributed to the annual value of -$1.2 million for FY2021, which is 7042.54% up from last year.
  • As of Q3 2025, Legend Biotech's Other Working Capital Changes stood at -$1.2 million, which was up 9103.62% from -$35.8 million recorded in Q2 2025.
  • Over the past 5 years, Legend Biotech's Other Working Capital Changes peaked at $12.2 million during Q1 2023, and registered a low of -$48.6 million during Q1 2025.
  • In the last 5 years, Legend Biotech's Other Working Capital Changes had a median value of -$12.2 million in 2023 and averaged -$12.9 million.
  • Its Other Working Capital Changes has fluctuated over the past 5 years, first plummeted by 1050224.36% in 2022, then skyrocketed by 43105.42% in 2023.
  • Quarter analysis of 5 years shows Legend Biotech's Other Working Capital Changes stood at -$575000.0 in 2021, then tumbled by 5544.35% to -$32.5 million in 2022, then surged by 62.55% to -$12.2 million in 2023, then fell by 11.81% to -$13.6 million in 2024, then skyrocketed by 91.04% to -$1.2 million in 2025.
  • Its Other Working Capital Changes was -$1.2 million in Q3 2025, compared to -$35.8 million in Q2 2025 and -$48.6 million in Q1 2025.